RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication
Artículo científico (JournalArticle)
Caenorhabditis elegans as an in vivo model to assess fucoidan bioactivity preventing Helicobacter pylori infection
[EN] Currently, Helicobacter pylori is the unique biological carcinogenic agent. The search for antimicrobial
alternatives to antibiotics against this pathogen has been categorized as a priority due to the drastic failure
associated with current applied antibiotic therapy. The present study assessed the bioactive antimicrobial
capability of fucoidan (¿Generally Recognized as Safe¿ approval ¿ European Commission December 2017)
from different species of Phaeophyceae algae (Fucus vesiculosus, Undaria pinnatifida, Macrocystis pyrifera) against H. pylori. All the studied fucoidans showed bacteriostatic and bactericidal effects at the
studied concentrations [5¿100] µg ml¿1 and exposure times [0¿7 days]. The most effective anti-H. pylori
fucoidan was validated in Caenorhabditis elegans as an in vivo model. C. elegans feed was supplemented
with Undaria pinnatifida [0¿100] µg ml¿1 fucoidan, resulting in a significant improvement in lifespan,
lowered H. pylori concentration in the digestive tract, and increased egg-laying pattern. New research
lines proposing this compound as an active agent in nutraceutical and preventive novel therapies should
be opened., The present research work has been supported by the funds provided by the Spanish Ministry of Economy and
Competitiveness (MINECO) under both projects with reference AGL2014-53875-R and AGL2017-86840-C2-2-R. M. C. PinaPérez is also grateful to the EC providing a H2020 MSCA IF Grant Agreement No. 748314.